ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    HLA Antibody Clonality and Epitopes Dictate Complement Activation.

    K. Thomas,1 N. Valenzuela,1 A. Mulder,2 E. Reed.1

    1Pathology and Laboratory Medicine, UCLA, Los Angeles, CA; 2Leiden University Medical Center, Leiden, Netherlands.

    Background: Alloimmunization results in production of polyclonal donor specific antibodies (DSA) against human leukocyte antigens (HLA), which mediate endothelial cell activation, leukocyte recruitment, and complement…
  • 2016 American Transplant Congress

    The Role and Mechanism of CD40/CD40L Expression on Different T-Cell Subsets.

    N. Granofszky, K. Hock, B. Mahr, N. Pilat-Michalek, T. Wekerle.

    Department of Surgery, Section of Transplantation Immunology, Medical University of Vienna, Vienna, Austria.

    Background: Several T-cell costimulatory pathways (i.e. CD28:B7 and CD40:CD40L) play a critical role in modulating alloreactivity, but their function on distinct T cell subsets remains…
  • 2016 American Transplant Congress

    Prospective Long-Term Analysis of B- and Plasma Cell Subsets in Renal Transplant Patients After Combined Treatment with Rituximab and Bortezomib in Antibody Mediated Rejection.

    M. Duerr, F. Halleck, O. Staeck, L. Lehner, D. Khadzhynov, S. Eva, J. Waiser, K. Budde.

    Nephrology, Charité Berlin, Berlin, Germany.

    Treatment of antibody-mediated rejection (AMR) in renal transplant (Tx) patients (pts) is still challenging and long-term outcome remain poor. Our present treatment strategy with bortezomib…
  • 2016 American Transplant Congress

    Early De Novo DSA with T Cell Mediated Rejection (TCMR) Is Associated with Allograft Dysfunction with Chronic Injury.

    A. Cherukuri, R. Mehta, P. Sood, A. Zeevi, S. Hariharan, D. Rothstein.

    UPMC, Pittsburgh.

    De novo anti-donor HLA specific antibody (DSA) detected post-renal transplantation is associated with adverse outcomes. However, the relationship between early de novo DSA and subsequent…
  • 2016 American Transplant Congress

    Center Volume Is Associated with Outcome Following Pancreas Transplantation within the Eurotransplant Region.

    W. Kopp,1,2 M. van Meel,2 H. Putter,3 U. Samuel,2 H. Arbogast,4 W. Schareck,5 J. Ringers,1 A. Braat.1

    1Surgery, Leiden University Medical Center, Leiden, Netherlands; 2Eurotransplant International Foundation, Leiden, Netherlands; 3Medical Statistics, Leiden University Medical Center, Leiden, Netherlands; 4General, Visceral, Transplant, Vascular and Thoracic Surgery, University of Munich – Grosshadern Medical Centre, Munich, Germany; 5University Medical Center Rostock, Rostock, Germany.

    Introduction Outcome following all kinds of surgery depends on several factors, amongst these the annual volume-outcome relationship. This might also be the case in a…
  • 2016 American Transplant Congress

    Long Term Results on Pancreas Transplant Beyond the Standard Indications, at a Single Center.

    D. Ramisch,1 N. Aguirre,1 F. Moss,2 P. Farinelli,1 R. Fortunato,2 L. Gutierrez,2 P. Barros Schelotto,1 H. Fraguas,3 P. Raffaele,2 G. Gondolesi.1

    1Instuto de Transplante Multiorganico, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina; 2Unidad de Trasplante Renal y Nefrologia, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina; 3Servicio de Cirugia Cardiovascular, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina.

    Introduction: Simultaneous kidney-pancreas (SKP) transplantation has become the best treatment option for patients with end stage renal disease (ESRD) and type 1 diabetes (T1D). In…
  • 2016 American Transplant Congress

    Use of Integrated National Registry and Pharmacy Claims Data to Identify Diabetes Mellitus After Live Pancreas Donation.

    K. Lentine,1,7 N. Lam,2 H. Randall,8 D. Axelrod,3 D. Segev,4,1 G. Hess,5 A. Garg,6 D. Brennan,7 B. Kasiske,8 M. Schnitzler.8,1

    1Scientific Registry of Transplant Recipients, Minneapolis; 2Univ Alberta, Alberta, Canada; 3Dartmouth, Hanover; 4Johns Hopkins, Baltimore; 5Symphony Health, Pittsburgh; 6Western Univ, London, Canada; 7Washington Univ, St. Louis; 8Saint Louis Univ, St. Louis.

    Living donor pancreas transplant is a potential treatment for diabetic patients with end-organ complications. Early post-donation surgical risks of living pancreas donation have been reported,…
  • 2016 American Transplant Congress

    Widespread Weight Gain After Pancreas Transplantation May Worsen Metabolic Graft Function.

    A. Gruessner, V. Whittaker, N. Ozden, R. Gruessner.

    Department of Surgery, SUNY Upstate Medical University, Syracuse, NY.

    Introduction: Outcome after pancreas transplantation (tx) has improved over time and an increasing number of recipients remain insulin independent and enjoy a better quality of…
  • 2016 American Transplant Congress

    Pancreatic Allograft Failure in Latino Recipients: Diabetes Mellitus Type 2 Conversion?

    H. Fernandez, G. McKenna, N. Onaca, R. Ruiz.

    Baylor University Medical Center, Dallas, TX.

    Introduction:Pancreas transplantation is the definitive treatment for diabetes mellitus (DM). The advantages of simultaneous kidney pancreas transplant in Latinos have been demonstrated previously, but there…
  • 2016 American Transplant Congress

    Impact of Simultaneous Pancreas-Kidney Transplantation versus Kidney Transplant Alone on Patient and Graft Survival in Type 2 Diabetics with Elevated BMI.

    S. Singh,1,2 S. Kim.1,2,3,4

    1Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Canada; 2Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; 3Division of Nephrology and the Multi-Organ Transplant Program, University Health Network, Toronto General Hospital, Toronto, Canada; 4Division of Nephrology and the Kidney Transplant Program, St. Michael's Hospital, Toronto, Canada.

    Background: Simultaneous Pancreas-Kidney transplantation (SPKT) is becoming increasingly common in patients with Type 2 diabetes (T2DM). The BMI threshold for listing for SPKT in this…
  • « Previous Page
  • 1
  • …
  • 1179
  • 1180
  • 1181
  • 1182
  • 1183
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences